Zygote-mediated generation of genome-modified mice using Streptococcus thermophilus 1-derived CRISPR/Cas system  by Fujii, Wataru et al.
lable at ScienceDirect
Biochemical and Biophysical Research Communications 477 (2016) 473e476Contents lists avaiBiochemical and Biophysical Research Communications
journal homepage: www.elsevier .com/locate/ybbrcZygote-mediated generation of genome-modiﬁed mice using
Streptococcus thermophilus 1-derived CRISPR/Cas system
Wataru Fujii a, *, Shigeru Kakuta b, Shin Yoshioka a, Shigeru Kyuwa b, Koji Sugiura a,
Kunihiko Naito a, **
a Department of Animal Resource Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, 113-8657, Japan
b Department of Biomedical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, 113-8657, Japana r t i c l e i n f o
Article history:
Received 26 May 2016
Accepted 14 June 2016
Available online 16 June 2016
Keywords:
Genome engineering
CRISPR/Cas
Knockout mice
Knockin mice* Corresponding author.
** Corresponding author.
E-mail addresses: awtrfj@mail.ecc.u-tokyo.ac.jp (W
tokyo.ac.jp (K. Naito).
http://dx.doi.org/10.1016/j.bbrc.2016.06.070
0006-291X/© 2016 The Authors. Published by Elseviera b s t r a c t
Mammalian zygote-mediated genome-engineering by CRISPR/Cas is currently used for the generation of
genome-modiﬁed animals. Here we report that a Streptococcus thermophilus-1 derived orthologous
CRISPR/Cas system, which recognizes the 50-NNAGAA sequence as a protospacer adjacent motif (PAM), is
useful in mouse zygotes and is applicable for generating knockout mice (87.5%) and targeted knock-in
mice (45.5%). The induced mutation could be inherited in the next generation. This novel CRISPR/Cas
can expand the feasibility of the zygote-mediated generation of genome-modiﬁed animals that require
an exact mutation design.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A clustered regularly interspaced short palindromic repeats
(CRISPR)-CRISPR-associated (Cas) system is currently used as a
highly efﬁcient in vivo genome engineering tool. A Streptococcus
pyogenes (Spy)-derived single-guide RNA (gRNA)-Cas9 complex,
which is commonly used as a conventional CRISPR/Cas tool, rec-
ognizes a speciﬁc DNA sequence containing a base-pairing region
and a protospacer adjacent motif (PAM) (50-NGG as a canonical
PAM or 50-NAG as a secondary PAM), and it induces a DNA double-
strand break (DSB) in the target locus [1e3]. The repair of a DSB by
error-prone non-homologous end-joining (NHEJ) is sometimes
accompanied by indel mutations, resulting in the disruption of
genome information in the target locus.
As well as such indel-mediated gene knockout by NHEJ, a DSB-
activated homologous-recombination repair reaction can generate
a knock-in mutation by introducing exogenous donor DNA as a
repair template with the gRNA-Cas9 complex. By applying these
systems to a mammalian zygote, various species of genome-
modiﬁed animals can be efﬁciently generated, including mouse
[4e8].. Fujii), aknaito@mail.ecc.u-
Inc. This is an open access article uIn addition to Spy, diverse eukaryote-derived CRISPR/Cas sys-
tems have been reported, and some of them require PAM sequences
that are different from that used with Spy-CRISPR/Cas. A Strepto-
coccus thermophilus-1 (St1)-derived CRISPR/Cas system has been
reported to recognize the 50-NNRGAA sequence as a PAM, and this
St1-CRISPR/Cas is expected to be useful as a genome-engineering
tool to modify the genome loci, where Spy-CRISPR/Cas is not
accessible [9e11]. In particular, it would contribute to the genera-
tion of single-nucleotide altered or short sequence-inserted ani-
mals, because the designable sequence of the gRNA for accurately
obtaining knock-in animals without indel mutations is strictly
limited. The application of this St1-CRISPR/Cas to zygote-mediated
gene modiﬁcation is thus expected to expand its utility. However,
the previous reports about the application of the St1-derived
CRISPR/Cas system were limited to mammalian culture cells, and
to the best of our knowledge there is no report about the applica-
tion of this system to zygote-mediated genome engineering.
In the present study, we attempted to apply the St1-derived
CRISPR/Cas system to zygote-mediated genome engineering, and
we successfully generated systemic knockout mice. In addition,
knock-in mice, which are difﬁcult to obtain by using a conventional
CRISPR/Cas system, were efﬁciently generated by the orthologous
CRISPR/Cas system.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Ethics statement
All animal care and experiments conformed to the Guidelines
for Animal Experiments of The University of Tokyo, and were
approved by the Animal Research Committee of The University of
Tokyo.
2.2. Construction of Cas9-and gRNA-plasmid DNA
The human codon optimized St1-Cas9 coding plasmid was ob-
tained from Addgene (#48669 [9]). The ORF sequence was ampli-
ﬁed by PCR and inserted into the NotI to ClaI site of pCAG-T3-
hCAS9-pA plasmid (Addgene #48625 [7]), which codes T3 pro-
moter and Tbpl1 30UTR and 95 nucleotides of poly-adenine. The
constructed plasmid vector was sequenced using a commercial
sequencing kit (Applied Biosystems, Foster City, CA, USA) and a
DNA sequencer (Applied Biosystems) according to the manufac-
turer’s instructions. The gRNA template DNA sequences with T3
promoter were synthesized by overlap-PCR using the primers
shown in Supplementary Table 1, and each PCR amplicon was sub-
cloned by the pGEM-T Easy system (Promega, Madison, WI). These
vectors were sequenced as described above. All of the sequence
information is provided in Supplementary Fig. 1.
2.3. In vitro transcription of Cas9 mRNA and gRNAs
The in vitro synthesis of Cas9 mRNA and gRNAwas performed as
described [7]. The RNA transcripts were precipitated with absolute
ethanol, washed and resuspended in RNase-free water (Gibco,
Grand Island, NY). The RNA solutions were stored at 80 C until
use.Fig. 1. Generation of Tyrosinase knockout mice using St1-derived CRISPR/Cas. (A) Schematic
dot and red sequences indicate the target loci of the gRNA and PAM, respectively. (B) The coa
in F0 pups. The hyphens and small letters indicate deletion and insertion nucleotides, respe
analyses of the F0 male and F1 pups. (For interpretation of the references to color in this ﬁ2.4. Microinjection and embryo-transfer
Sexually immature female C57BL/6JJcl mice (4 weeks old) were
superovulated by an intraperitoneal injection of 7.5 IU equine
chorionic gonadotropin (eCG) followed by 7.5 IU human chorionic
gonadotropin (hCG) at an interval of 48 h andmated overnight with
12-week-old C57BL/6JJcl male mice. Zygotes were collected from
oviductal ampulla 20e21 h after the hCG injection, and pronuclei-
formed zygotes were put into M2 medium.
The microinjection was performed using a microinjector (Nar-
ishige, Tokyo)-equipped microscope. Approximately 4 pl of RNA
solution, that contained 100 ng/ml of Cas9 mRNA and 10 ng/ml of
gRNA for knockout experiment or 10 ng/ml of Cas9 mRNA, 10 ng/ml
of gRNA and 100 ng/ml single-strand oligodeoxynucleotide (ssODN)
shown in Supplementary Table 1 for only the knock-in experiment,
was injected into the cytoplasm of each zygote using continuous
pneumatic pressure. After the injection, all zygotes were cultured in
M16 medium for 24 h, and two-cell embryos were transferred into
the oviduct of 0.5 days post coitum pseudopregnant ICR females.
After the pups’ birth, genome DNA was extracted from the tail
tips and subjected to PCR for on-target locus and off-target loci
(Supplementary Table 3) using primer sets shown in
Supplementary Table 2. The PCR products were puriﬁed by agarose
gel electrophoresis, and the extracted fragments were directly
sequenced as described above. The predictive mutation pattern of
each allele was analyzed by sequence data as described [7].
3. Results
We ﬁrst attempted to generate Tyrosinase knockout mice by
using St1-derived CRISPR/Cas. We injected the gRNA targeting
Tyrosinase exon1 (Fig. 1A) and Cas9 mRNA into C57BL/6 zygotes,
and 40 injected zygotes were transferred into the oviduct of 2illustration of the Tyrosinase gene structure and sequences around the target loci. Black-
t color appearance of the obtained F0 mice. (C) The induced indel patterns of target loci
ctively. Red letters of the WT indicate PAM. (D) A pedigree obtained from the sequence
gure legend, the reader is referred to the web version of this article.)
Fig. 2. Generation of pIL1aK85E mice using St1-derived CRISPR/Cas with ssODN. (A)
Schematic illustration of the pIL1a structure, sequences around the target loci and the
ssODN sequence used as the repair template of homologous recombination. Red letters
indicate the target codon for alteration. Blue and green lines are target sequences
(boxes indicate the PAM) of Spy- and St1-CRISPR/Cas, respectively. (B) A wave form of
the target locus in an pIL1aK85E mouse generated by St1-derived CRISPR/Cas, and (C) a
wave form of a next-generation mouse. The arrowed sequences indicate the target
codon. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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(87.5%) showed white coat color; six showed white on their whole
bodies and one showed a mosaic pigmentation pattern, and one
pup was black (Fig. 1B).
We examined the target sequences by performing direct
sequencing of the polymerase chain reaction (PCR) product using
the tail-derived genome. The results showed various patterns of
indel-mutations in the target locus of all pups including the black
pup (Fig. 1C), whereas the sequencing of potential off-target loci
(Supplementary Table 3) showed no indel mutation. One biallelic
founder male was mated with a wild-type female, and nine next-
generation pups were obtained. All of the F1 pups had mutation
alleles, the same as the founder male (Fig. 1D), indicating that the
mutations induced by the St1-CRISPR/Cas system are heritable in
the next generation. These results revealed that the St1-CRISPR/Cas
system is available for the efﬁcient generation of gene-knockout
mice by zygote-mediated genome engineering, as can be done
with the conventional Spy-CRISPR/Cas.
We next attempted to generate knock-in mice, which are difﬁ-
cult to obtain with the conventional Spy-CRIPSR/Cas system. It was
reported that pro-interleukin 1 alpha (pIL1a) functions in the nu-
cleus in cellulo and that its lysine 85 (K85) is a part of the nuclear
locating signal (NLS) [12]. The NLS-disruption mutation, a
replacement of K85 by E, was reported in culture cells, and the
generation of the NLS-mutated mice is expected to be useful for
analyses of the in vivo functions of nuclear-localized pIL1a.
For the induction of single nucleotide polymorphism (SNPs) or
codon alterations by CRISPR/Cas, the efﬁciency of accurate muta-
tion without indel mutations dramatically increases when a PAM
can be designed based on the target nucleotides. For the induction
of pIL1aK85E, we could not obtain a canonical PAM of Spy-CRISPR/
Cas (50-NGG), but we were able to obtain a secondary PAM of
Spy-CRISPR/Cas (50-NAG) [3,13] and a PAM of St1-CRISPR/Cas (50-
NNAGAA) based on the target codon (Fig. 2A). We introduced one
each of these designed Spy- and St1-CRISPR/Cas into C57BL/6 zy-
gotes, and 19 and 12 pups were obtained, respectively (Table 1).
The direct sequencing of the PCR product using the tail-derived
genome revealed that the almost all of Spy-CRISPR/Cas-introduced
pups showed nomutation on the target locus and that only one pup
(5.3%) had a targeted nucleotide alteration. However, the mutated
pup had an unexpected indel mutation around the target locus, and
therefore no accurate mutated mouse was obtained by Spy-CRISPR/
Cas (Table 1). In contrast, 11 of St1-CRISPR/Cas-introduced pups
(91.7%) showed genome modiﬁcation in the target locus, and ﬁve
(45.5%) of them contained accurate nucleotide alteration (Table 1,
Fig. 2B). A founder male and female which had K85E mutations
were mated, and seven next-generation pups were obtained. All of
the next generation pups contained K85E mutation alleles, and ﬁve
of the seven pups (71.4%) were biallelic mutants (Fig. 2C) whereas
the other two pups were monoallelic, indicating that the founder
mice had mosaicism in their gonads and that the majority of the
germline cells had biallelic mutations. These results revealed that
the St1-CRISPR/Cas-induced knockin allele could be inherited in
the next generation, and that the St1-CRISPR/Cas system is useful
for the efﬁcient generation of knock-in mice, which are difﬁcult to
obtain using the conventional CRISPR/Cas.
4. Discussion
The results of this study revealed that St1-derived CRISPR/Cas,
which could target the PAM sequence that is different from the
conventional Spy-CRISPR/Cas system, could be applied to zygote-
mediated genome engineering and the generation of knockout
and knock-in mice. In the present study, all of the embryos with
induced Tyrosinase-targeted St1-CRISPR/Cas had mutations at thetarget locus, and 75% of them were complete biallelic mutants.
When pIL1a-targeted St1-CRISPR/Cas was treated with the donor
template DNA, 91.7% of the embryos were mutated at the target
locus and 45.5% had accurate knock-inmutations. These efﬁciencies
of genome engineering were the same or greater than those of
reported studies using Spy-CRISPR/Cas systems and mammalian
zygotes [4e8]. Although the usefulness of St1-CRISPR/Cas for gene
engineering and its comparable efﬁciencies with those of Spy-
CRISPR/Cas have been reported only in cultured somatic cells, we
revealed for the ﬁrst time that St1-CRISPR/Cas efﬁciently func-
tioned in murine zygotes as well.
To generate a gene knockout animal, various loci are selectable
for the target of gRNA because the target gene can be disrupted by
inducing themutation in any sequences related to the expression of
the gene, such as promoter-, open reading frame-, or splicing-
related sites. Target sequences of CRISPR/Cas to generate the
knock-in mutations are much more limited because the gRNA
should be designed to not recognize the target locus after the
completion of the homologous recombination-mediated knock-in
mutation. As CRISPR/Cas has off-target activity that induces the
indel mutations at unexpected loci similar to the target locus, Cas9/
gRNAwould recognize the modiﬁed-target locus and induce NHEJ-
mediated indel mutations even if the target sequence is changed by
nucleotide alterations.
For the stable induction of a small nucleotide alteration,
disruption of the PAM sequence is a prerequisite for the designation
of donor DNA in addition to the target nucleotide alterations [4].
The disruption of a PAM induces the loss of Cas9-gRNA-complex
afﬁnity to the target locus and avoids the re-introduction of a DSB,
Table 1
Generation efﬁciency of pIL1aK85E mice using different CRISPR/Cas systems.
No. of obtained pups No (%). of pups with mutationa No (%). of pups with precise KIb
Spy-CRISPR/Cas 19 1 (5.3) 0 (0)
St1-CRISPR/Cas 12 11 (91.7) 5 (45.5)
a Pups showing mutations at the target locus.
b Pups showing a precise targeted nucleotide alteration without indel mutations.
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[14]. As the induction of a silent mutation in the PAM sequence has
some risks caused by the codon-usage change, it is ideal to design
the targeting nucleotide based on the PAM sequence. Our present
ﬁndings demonstrated that St1-derived CRISPR/Cas could target a
locus that was difﬁcult to target by conventional Spy-CRISPR/Cas
from this point of view, and we were able to induce accurate
nucleotide alteration at comparable efﬁciency with Spy-CRISPR/
Cas. Our ﬁndings may contribute to the expansion of the use of
CRISPR/Cas to generate zygote-mediated genome-modiﬁed mice
requiring exact mutation designs.
Although it has been reported that conventional Spy-CRISPR/Cas
could generate point-mutation pups efﬁciently (50%e80%), we
could not obtain any point-mutation pups by Spy-CRISPR/Cas in
this study. The target sequence of Spy-CRISPR/Cas for the present
knock-in experiment had to adopt a secondary PAM (50-NAG)
instead of the primary PAM (50-NGG), and this would cause reduced
DSB induction efﬁciency.
It has been reported that there are many CRISPR/Cas systems
other than St1-CRISPR/Cas that recognize various PAM sequences.
For example, Francisella novicida-derived CRISPR/Cas could recog-
nize 50-NG as a PAM [11], and Neisseria meningitidis-derived
CRISPR/Cas recognized 50-NNNNGATT as a PAM [9]. Similar to these
class 1 CRISPR systems, a class 2 CRISPR system, which uses Cpf1 as
a single RNA-guided endonuclease instead of Cas9, could recognize
TTT as a PAM [15]. These orthologous or other class CRISPR/Cas
systems should be usable as gene engineering tools in vitro and in
cellulo. In addition, Spy-CRISPR/Cas could recognize a locus other
than 50-NGG or 50-NAG as a PAM bymutation induction in the PAM-
recognizing domains of Cas9 protein [16].
If such CRISPR/Cas systems function with high efﬁciency in zy-
gotes by the same procedure as conventional or St1-CRISPR/Cas,
zygote-mediated generations of genome-engineered animals
might be more expanded with modiﬁcations that are difﬁcult to
generate with a conventional CRISPR/Cas system. It necessary to
conduct further studies to conﬁrm whether these new CRISPR/Cas
systems can truly act effectively in mammalian zygotes.
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